Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nina Garlie"'
Autor:
William G. Matthaeus, Jamie Huebschen, Robert Taylor, Federico Sanchez, Nina Garlie, Jaime Kroll
Publikováno v:
Biology of Blood and Marrow Transplantation. 22(3)
Autor:
Jonathan Treisman, Nina Garlie
Publikováno v:
Clinics in Plastic Surgery. 37:127-146
This article provides a review of the current medical management of patients with high-risk and metastatic cutaneous melanoma, including a review of the use of adjuvant interferon therapy and a discussion of adjuvant treatments under evaluation. The
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S276
Publikováno v:
Journal of Immunotherapy. 24:408-419
Anti-CD3/anti-CD28 monoclonal antibody-coactivated T cells (COACTs) proliferate, secrete tumoricidal cytokines, and mediate non-major histocompatibility complex (MHC)-restricted cytotoxicity. This phase I study was done to determine the safety, maxim
Autor:
Dennis Van Epps, Ann V. Lefever, Lawrence G. Lum, Ruth E. Siebenlist, Dawn M. Wankowski, Manjula Sen, Nina Garlie
Publikováno v:
Journal of Hematotherapy & Stem Cell Research. 10:247-260
Relapse after adjuvant chemotherapy or high-dose chemotherapy with stem cell transplant for high-risk breast cancer remains high and new strategies that provide additional antitumor effects are needed. This report describes methods to generate highly
Autor:
Ann V. Lefever, Bruce L. Levine, Lawrence G. Lum, Carl H. June, Nina Garlie, Ruth E. Siebenlist
Publikováno v:
Journal of Immunotherapy. 22:336-345
This report describes the generation of T cells with characteristics that may prove useful for the immunotherapy of cancer. Peripheral blood mononuclear cells obtained from healthy donors were cultured in the presence of anti-CD3/anti-CD28 mAb-coated
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology. 81(5)
Adoptive transfer of tumor-infiltrating lymphocytes (TIL) is in development for the treatment of metastatic melanoma. In phase II clinical trials, patients with metastatic melanoma that received TIL after preconditioning had a 50-70% clinical respons
Autor:
Jayant Khitha, Eric G. Schmuck, Jill M. Koch, Timothy A. Hacker, Indrajit Choudhuri, Nina Garlie, Amish N. Raval
Publikováno v:
Journal of Patient-Centered Research and Reviews. 2:215
Autor:
Carol Halliday, Anand Padmanabhan, William G. Matthaeus, Angela M. Timler, Federico Sanchez, Nina Garlie, Robert Talatzko, Katherine Dennert, Robert Taylor
Publikováno v:
Cytotherapy. 17:S60
203 OPTIMIZING PBSC COLLECTION FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION AM Timler, K Dennert, R Talatzko, III, C Halliday, A Padmanabhan, W Matthaeus, F Sanchez, R Taylor, N Garlie Regenerative Medicine Center, Aurora St. Luke’s Medical Center,
Autor:
Nina Garlie, Angela M. Timler
Publikováno v:
Journal of Immunotherapy. 28:613